MDMA-Assisted Therapy for PTSD: Clinical Brochure

MDMA-Assisted Therapy for Posttraumatic Stress Disorder
Clinical Brochure


  1. Bradley, R., et al., A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry, 2005. 162(2): p. 214-27.
  2. Foa, E.B., et al., A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol, 1999. 67(2): p. 194-200.
  3. Resick, P.A. and M.K. Schnicke, Cognitive processing therapy for sexual assault victims. J Consult Clin Psychol, 1992. 60(5): p. 748-56.
  4. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Revision). Washington, DC.
  5. Perkonigg, A., et al., Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity. Acta Psychiatr Scand, 2000. 101: 46-59.
  6. Breslau, N., The epidemiology of posttraumatic stress disorder: what is the extent of the problem? J Clin Psychiatry, 2001. 62 Suppl 17: p. 16-22.
  7. Kessler, R.C., Berglund, P., Delmer, O., Jin, R., Merikangas, K.R., & Walters, E.E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6): 617-27.
  8. de Jong, J.T., I.H. Komproe, and M. Van Ommeren, Common mental disorders in postconflict settings. Lancet, 2003. 361: 2128-30.
  9. Statement Of Jon A. Wooditch Acting Inspector General Department Of Veterans Affairs, in Committee On Veterans’ Affairs Subcommittee On Disability Assistance And Memorial Affairs. 2005: Washington, DC.
  10. Tanielian, T.L., L. Jaycox, and Rand Corporation., Invisible wounds of war : psychological and cognitive injuries, their consequences, and services to assist recovery. 2008, Santa Monica, CA: RAND. xliii, 453 p.
  11. Kuypers, K.P.C. and Ramaekers, J.G., Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine. J of Psychopharmacology (2005) 19(6): 633‐639
  12. Bedi, G., et al. Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (2009) 207: 73‐83.
  13. Greer, G.R. and R. Tolbert, A method of conducting therapeutic sessions with MDMA. J Psychoactive Drugs, 1998. 30(4): p. 371-379.
  14. Mithoefer, M.C., et al., The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol, 2010. 25(4): 439-452.
  15. Bradley, R., et al., A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry, 2005. 162(2): p. 214-27.
  16. Heresco-Levy, U., et al., Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol, 2002. 5(4): p. 301-7.
  17. Brady, K., et al., Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA, 2000. 283(14): p. 1837-44.
  18. Friedman, M.J., et al., Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry, 2007. 68(5): p. 711-20.
  19. Ogden PKM and Pain C (2006) Trauma and the body. New York, NY: W.W. Norton & Company. (Berl) 189: 565–573.
  20. Passie T, Hartmann U, Schneider U, Emrich HM and Kruger TH Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion. Med Hypotheses, 2005. 64: 899–903.
  21. Gamma, A., et al., 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans. Neuropsychopharmacology, 2000. 23(4): p. 388-95.
  22. Grob, C.S., et al., Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res, 1996. 73(1-2): p. 103-7.
  • Prospectus: Clinical Development Plan for MDMA-Assisted Therapy for PTSD